$0.01
(Market cap
$24 Mln
Revenue (TTM)
$57 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1 %
-
ROCE
-- %
-
Industry P/E
37.32
-
EV/EBITDA
1.1
-
Debt to Equity
0.3
-
Book Value
$3.3
-
EPS
$-4.4
-
Face value
--
-
Shares outstanding
10,733,208
10 Years Aggregate
CFO
$-154.68 Mln
EBITDA
$-60.35 Mln
Net Profit
$-310.56 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aytu BioScience Inc (AYTU)
| -13.5 | 9.2 | 1.8 | -3.4 | 8.9 | -50.2 | -69.3 |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Aytu BioScience Inc (AYTU)
| 52.9 | -39.9 | -24.9 | -85.9 | -77.4 | -38.5 | 22.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aytu BioScience Inc (AYTU)
|
2.3 | 24.2 | 56.6 | -34.1 | -55.5 | -116.8 | -- | 0.7 |
| 17.5 | 6,109.1 | 3,117.6 | 157.4 | 14.7 | -- | 37.3 | 190.1 | |
| 199.0 | 10,424.8 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 129.6 | |
| 76.6 | 14,974.8 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 113.9 | 12,310.3 | 830.8 | 54.9 | 3.2 | 8.1 | 264.8 | 17.9 | |
| 12.2 | 10,087.6 | 332,834.2 | 33,166.6 | 11.1 | 8.9 | 28.8 | 2.5 | |
| 24.1 | 11,971.8 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.8 | |
| 280.5 | 5,591.7 | 290.5 | 197.2 | 82.5 | 19.9 | 28.9 | 5.9 | |
| 67.7 | 6,058.9 | 450.9 | 138.6 | 39.1 | 115.6 | 50.1 | 32.1 | |
| 141.4 | 8,865.6 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 21.5 |
Shareholding Pattern
View DetailsAbout Aytu BioScience Inc (AYTU)
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD),... including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado. Read more
-
Chairman & CEO
Mr. Joshua R. Disbrow
-
Chairman & CEO
Mr. Joshua R. Disbrow
-
Headquarters
Denver, CO
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Aytu BioScience Inc (AYTU)
What is the current share price of Aytu BioScience Inc (AYTU) Today?
The share price of Aytu BioScience Inc (AYTU) is $2.25 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Aytu BioScience Inc (AYTU) has given a return of 8.95% in the last 3 years.
What is the current PB & PE ratio of Aytu BioScience Inc (AYTU)?
Since, TTM earnings of Aytu BioScience Inc (AYTU) is negative, P/E ratio is not available.
The P/B ratio of Aytu BioScience Inc (AYTU) is 0.69 times as on 28-Aug-2026, a 91 discount to its peers’ median range of 7.75 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.09 |
0.78 |
2024 |
-1.02 |
0.58 |
2023 |
-0.52 |
0.22 |
2022 |
-0.01 |
0.03 |
2021 |
-0.10 |
0.04 |
What is the 52 Week High and Low of Aytu BioScience Inc (AYTU)?
The 52-week high and low of Aytu BioScience Inc (AYTU) are Rs 3.07 and Rs 1.65 as of 31-Aug-2026.
What is the market cap of Aytu BioScience Inc (AYTU)?
Aytu BioScience Inc (AYTU) has a market capitalisation of $ 24 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Aytu BioScience Inc (AYTU)?
Before investing in Aytu BioScience Inc (AYTU), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.